Literature DB >> 15219343

Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users.

Raffaella M Milani1, Andy C Parrott, John J D Turner, Helen C Fox.   

Abstract

Previous research has found gender differences in both psychological and physiological responses to drugs. The present investigation explores gender variability in patterns of drug use in relation to self-reported depression, anxiety, and somatization. The current study confirms that heavy illegal drug users are represented by a preponderance of males than females. However, within each drug group category, females generally reported higher psychopathology scores than males. This was significant for all three subscales in the alcohol/tobacco group, for depression scores in the alcohol/tobacco, cannabis/alcohol, and light Ecstasy users group, and for depression scores for the alcohol group. Interestingly, in the male sample, drug users reported higher symptom ratings than nondrug users, whereas women's scores remained constant across drug groups. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219343     DOI: 10.1016/j.addbeh.2004.02.044

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  13 in total

1.  Prevalence and predictors of club drug use among club-going young adults in New York city.

Authors:  Brian C Kelly; Jeffrey T Parsons; Brooke E Wells
Journal:  J Urban Health       Date:  2006-09       Impact factor: 3.671

2.  Gender differences in cardiovascular and corticoadrenal response to stress and drug cues in cocaine dependent individuals.

Authors:  Helen C Fox; Miguel Garcia; Kathleen Kemp; Verica Milivojevic; Mary Jeanne Kreek; Rajita Sinha
Journal:  Psychopharmacology (Berl)       Date:  2006-03-03       Impact factor: 4.530

3.  Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats.

Authors:  Q David Walker; Christina N Williams; Rakesh P Jotwani; Samuel T Waller; Reynold Francis; Cynthia M Kuhn
Journal:  Psychopharmacology (Berl)       Date:  2006-09-23       Impact factor: 4.530

4.  Are ecstasy users biased toward endorsing somatic mental health symptoms? Results from a general community sample.

Authors:  Amanda M George; Tim D Windsor; Bryan Rodgers
Journal:  Psychopharmacology (Berl)       Date:  2010-12-08       Impact factor: 4.530

5.  Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.

Authors:  John J D Turner; Andrew C Parrott; Julia Goodwin; Derek G Moore; Sarah Fulton; Meeyoung O Min; Lynn T Singer
Journal:  J Psychopharmacol       Date:  2013-12-10       Impact factor: 4.153

6.  Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use.

Authors:  Krista Lisdahl Medina; Paula K Shear
Journal:  Drug Alcohol Depend       Date:  2006-10-30       Impact factor: 4.492

7.  During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study.

Authors:  Derek G Moore; John D Turner; Andrew C Parrott; Julia E Goodwin; Sarah E Fulton; Meeyoung O Min; Helen C Fox; Fleur M B Braddick; Emma L Axelsson; Stephanie Lynch; Helena Ribeiro; Caroline J Frostick; Lynn T Singer
Journal:  J Psychopharmacol       Date:  2009-11-25       Impact factor: 4.153

8.  Typology of club drug use among young adults recruited using time-space sampling.

Authors:  Danielle E Ramo; Christian Grov; Kevin Delucchi; Brian C Kelly; Jeffrey T Parsons
Journal:  Drug Alcohol Depend       Date:  2009-11-24       Impact factor: 4.492

9.  Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database.

Authors:  Traci C Green; Jill M Grimes Serrano; Andrea Licari; Simon H Budman; Stephen F Butler
Journal:  Drug Alcohol Depend       Date:  2009-05-05       Impact factor: 4.492

10.  Multisubstance Use Among Treatment-Seeking Smokers: Synergistic Effects of Coping Motives for Cannabis and Alcohol Use and Social Anxiety/Depressive Symptoms.

Authors:  Dawn W Foster; Julia D Buckner; Norman B Schmidt; Michael J Zvolensky
Journal:  Subst Use Misuse       Date:  2016-02-04       Impact factor: 2.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.